UTMD Insider Trading Activity and SEC Form 4 Filings
UTMD insider trading summary
Over the past 12 months, insiders at Utah Medical Products Inc (UTMD) reported 1 open-market purchase worth $67K by 1 insider and no sales on SEC Form 4. Net insider buying was $67K.
Latest UTMD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 29, 2026 | Kevin L Cornwell | Chairman, CEO | Buy | $67K (1,000 @ $66.75) |
| May 18, 2023 | Paul O Richins | Director | Sell | $65K (700 @ $93.47) |
| Nov 18, 2022 | Paul O Richins | Director | Sell | $41K (449 @ $90.81) |
| Nov 17, 2022 | Paul O Richins | Director | Sell | $14K (161 @ $90.00) |
| Nov 11, 2022 | Paul O Richins | Director | Sell | $4K (40 @ $92.50) |
| May 11, 2022 | Barbara A Payne | Director | Sell | $170K (2,000 @ $85.20) |
| Nov 24, 2021 | Ernst G Hoyer | Director | Sell | $619K (4,900 @ $126.41) |
| Nov 23, 2021 | Ernst G Hoyer | Director | Sell | $13K (100 @ $125.01) |
| Nov 18, 2021 | Barbara A Payne | Director | Sell | $139K (1,249 @ $111.06) |
| Nov 17, 2021 | Barbara A Payne | Director | Sell | $83K (751 @ $111.06) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.